Different CD3/T cell receptor monoclonal antibodies have distinct capacities to induce adhesion of T lymphocytes to endothelium

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 1, 1997, Pages 91-101

  Buysmann, Saskia ^b   Schellekens, Peter Th A ^b   Tax, Wil J M ^b   Ten Berge, Ineke J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031194386     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90063-9     Document Type: Article

References (36)

1. Parlevliet KJ, Jonker M, ten Berge RJM, et al. Anti-CD3 murine monoclonal isotype switch variants tested for toxicity and immunologic monitoring in four chimpanzees. Transplantation 1990;50:889-92.
2. Parlevliet KJ, ten Berge RJM, Yong SL, Surachno S, Wilmink JM, Schellekens PThA. In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants. J Clin Invest 1994; 93:2519-25.
3. Parlevliet KJ, ten Berge RJM, Raasveld MHM, Surachno S, Wilmink JM, Schellekens PThA. Low-dose OKT3 induction therapy following renal transplantation: a controlled study. Nephrol Dial Transplant 1994;9:698-703.
4. Buysmann S, Bemelman FJ, Schellekens PThA, van Kooyk Y, Figdor CG, ten Berge RJM. Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. Blood 1996;87:404-11.
5. Abramowicz D, Schandene L, Goldman M, et al. Release of tumor necrosis factor, interleukin-2 and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 1989;47:606-8.
6. Chatenoud L, Ferran C, Reuter A, et al. Systemic reaction to the anti-T cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-γ. N Engl J Med 1989;320:1420-1.
7. Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988;107:321-31.
8. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-11.
9. Pober JS, Gimbrone MA, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986;137:1893-6.
10. Graber N, Venkat Gopal T, Wilson D, Beall LD, Polte T, Newman W. T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1. J Immunol 1990;145:819-30.
11. Van Lier RA, Boot JH, de Groot ER, Aarden LA. Induction of T cell proliferation with anti-CD3 switch variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems. Eur J Immunol 1987;17:1599-604.
12. Spits H, Borst J, Tax WJM, Capel PJA, Terhorst C, de Vries JE. Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen. J Immunol 1985;135:1922-8.
13. Tax WJM, Tamboer WPM, Jacobs CWM, Frenken LAM, Koene RAP. Role of polymorphic Fc receptor FcγRIIa in cytokine release and adverse effects of mIgGI anti-CD3/ TCR antibody (WT31) Transplantation 1997;63:106-12.
14. Van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993;14:215-21.
15. Tax WJM, Hermes FFM, Willems RW, Capel PJA, Koene RAP. Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation. J Immunol 1984;133:1185-9.
16. Frenken LAM, Koene RAP, Tax WJM. The role of antibody isotype in IFN-γ and IL-2 production during anti-CD3-induced T cell proliferation. Transplantation 1991;51:881-7.
17. Jiskoot W, van Hertrooij JJ, Hoven AM, et al. Preparation of clinical grade monoclonal antibodies from serum-containing cell culture supernatants. J Immunol Methods 1991;138:273-83.
18. Parren PWHI, Warmerdam PAM, Boeije LCM, Capel PJA, van de Winkel JGJ, Aarden LA. Characterization of IgG FcR-mediated proliferation of human T cells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3. J Immunol 1992;148:695-701.
19. Antoun GR, Longenecker BM, Zipf TF. Comparison of the 40 kDa hematopoietic cell antigens bound by monoclonal antibodies IV.3, 41H16 and KB61. Mol Immunol 1989;26: 333-8.
20. Gosselin EJ, Brown MF, Anderson CL, Zipf TF, Guyre PM. The monoclonal antibody 41H16 detects the Leu 4 responder form of human FcγRII. J Immunol 1990;144:1817-22.
21. Kolk AHJ, Ho MLY, Klatser PR, et al. Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae. Clin Exp Immunol 1984;58:511-21.
22. Figdor CG, van Kooyk Y, Keizer GD. On the mode of action of LFA-1. Immunol Today 1990;11:277-80.
23. 2+-dependent epitope stimulates lymphocyte adhesion. J Cell Biol 1991;112:345-54.
24. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989; 341:619-24.
25. Fontijn R, Hop C, Brinkman HJ, et al. Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Exp Cell Res 1995;216:199-207.
26. Sanchez-Madrid F, Krensky AM, Ware CF, et al. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci USA 1982;79:7489-93.
27. Keizer GD, Visser W, Vliem M, Figdor CG. A monoclonal antibody (NKI-L16) directed against a unique epitope on the α-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J Immunol 1988; 140:1393-400.
28. Keizer GD, Borst J, Figdor CG, et al. Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150,95. Eur J Immunol 1985;15:1142-8.
29. Hack CE, Paardekooper J, Smeenk RJT, Abbink J, Eerenberg AJM, Nuijens JH. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. J Immunol 1988;141:1602-9.
30. ten Berge RJM, Sauerwein HP, Yong SL, Schellekens PThA. Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes. Clin Immunol Immunopathol 1984;30:91-103.
31. Buysmann S, van Diepen FNJ, Yong SL, Surachno S, Schellekens PThA, ten Berge RJM. Mechanism of lymphocytopenia following administration of corticosteroids. Transplant Proc 1995;27:871-2.
32. Raasveld MHM, Bemelman FJ, Schellekens PThA, et al. Complement activation during OKT3 treatment: a possible explanation for respiratory side effects. Kidney Int 1993;43: 1140-9.
33. Figdor CG, van Kooyk Y, Keizer GD. On the mode of action of LFA-1. Immunol Today 1990;11:277-80.
34. Muto S, Vetvicka V, Ross GD. CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is up-regulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J Clin Immunol 1993;13:175-84.
35. Van Lier RAW, Boot JHA, Verhoeven AJ, de Groot ER, Brouwer M, Aarden LA. Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by anti-CD3. J Immunol 1987;139: 2873-9.
36. Shimizu Y, Newman W, Venkat Gopal T, et al. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1 and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 1991;113:1203-12.